SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-012251
Filing Date
2022-08-04
Accepted
2022-08-04 16:35:35
Documents
77
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q chrs-20220630x10q.htm   iXBRL 10-Q 2309771
2 EX-10.1 chrs-20220630xex10d1.htm EX-10.1 52836
3 EX-31.1 chrs-20220630xex31d1.htm EX-31.1 14070
4 EX-31.2 chrs-20220630xex31d2.htm EX-31.2 14966
5 EX-32.1 chrs-20220630xex32d1.htm EX-32.1 12067
  Complete submission text file 0001558370-22-012251.txt   8453513

Data Files

Seq Description Document Type Size
6 EX-101.SCH chrs-20220630.xsd EX-101.SCH 58914
7 EX-101.CAL chrs-20220630_cal.xml EX-101.CAL 62409
8 EX-101.DEF chrs-20220630_def.xml EX-101.DEF 245370
9 EX-101.LAB chrs-20220630_lab.xml EX-101.LAB 445806
10 EX-101.PRE chrs-20220630_pre.xml EX-101.PRE 388050
71 EXTRACTED XBRL INSTANCE DOCUMENT chrs-20220630x10q_htm.xml XML 1440787
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36721 | Film No.: 221137233
SIC: 2836 Biological Products, (No Diagnostic Substances)